Find clinical trials for Prostate Cancer in Madrid, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Madrid, MD, ESP:
primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...
Phase 2
Madrid, Spain and 11 other locations
to evaluate the efficacy and safety of talazoparib (PF-06944076) in combination with enzalutamide in patients with metastatic hormone-naïve prostate...
Phase 2
Madrid, Spain and 7 other locations
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...
Phase 1, Phase 2
Madrid, Spain and 12 other locations
The study will be conducted in 4 parts and will commence with dose escalation of AMX-500 as a monotherapy (Part 1), followed by monotherapy dose expa...
Phase 1, Phase 2
Madrid, Spain and 7 other locations
Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...
Phase 2, Phase 3
Madrid, Spain and 29 other locations
Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...
Phase 1
Madrid, Spain and 19 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Madrid, Spain and 52 other locations
to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...
Phase 4
Madrid, Spain and 53 other locations
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Madrid, Spain and 28 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Madrid, Spain and 131 other locations
Clinical trials
Research sites
Resources
Legal